Tatva Chintan Pharma Chem Sales and Profits Analyzed

Tatva Chintan Pharma Chem is doing really well! Their sales jumped a huge 53% – from Rs 85.90 crore to Rs 131.33 crore – during the last three months. This increase in sales led to a massive rise in their profits.

Key Points

• Sales soared 53%, reaching Rs 131.33 crore.
• Net profit jumped 10736%, to Rs 15.17 crore.
• Operating Profit Margin (OPM) improved to 19.41%.
• Profit Before Tax (PBDT) increased by 300%.
• Profit After Tax (PAT) rose dramatically to Rs 15.17 crore.
• Strong performance driven by Capital Market activity.

The company’s net profit also went up dramatically, increasing by 10736% to Rs 15.17 crore compared to just Rs 0.14 crore the previous quarter. This shows a significant improvement in how well the company is managing its money and producing goods. The operating profit margin increased to 19.41% during this period.

Before calculating the net profit, let’s look at the Profit Before Tax (PBDT), which rose by 300% to Rs 26.73 crore. This means the company’s core business operations are generating substantially more profit before considering other expenses and taxes.

Finally, the Profit After Tax (PAT) reached Rs 15.17 crore. This is the bottom line – the profit the company kept after paying all its bills and taxes. This represents a phenomenal growth of 10736% over the previous quarter.

Ultimately, Tatva Chintan Pharma Chem’s dramatic growth highlights significant market opportunity and strategic execution.